1951 Stock Overview
An investment holding company, provides assisted reproductive services (ARS) in China and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Jinxin Fertility Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.86 |
| 52 Week High | HK$4.64 |
| 52 Week Low | HK$2.07 |
| Beta | 1.44 |
| 1 Month Change | -11.46% |
| 3 Month Change | 11.28% |
| 1 Year Change | -10.90% |
| 3 Year Change | -45.73% |
| 5 Year Change | -73.57% |
| Change since IPO | -69.18% |
Recent News & Updates
Recent updates
Market Participants Recognise Jinxin Fertility Group Limited's (HKG:1951) Earnings Pushing Shares 28% Higher
Apr 10
Investors Still Waiting For A Pull Back In Jinxin Fertility Group Limited (HKG:1951)
Feb 07Returns On Capital Signal Tricky Times Ahead For Jinxin Fertility Group (HKG:1951)
Jan 06Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 09Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Nov 13Jinxin Fertility Group Limited's (HKG:1951) 30% Jump Shows Its Popularity With Investors
Sep 27Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Sep 02Jinxin Fertility Group (HKG:1951) Will Want To Turn Around Its Return Trends
May 30After Leaping 25% Jinxin Fertility Group Limited (HKG:1951) Shares Are Not Flying Under The Radar
May 13These 4 Measures Indicate That Jinxin Fertility Group (HKG:1951) Is Using Debt Reasonably Well
May 05What Is Jinxin Fertility Group Limited's (HKG:1951) Share Price Doing?
Mar 12Capital Allocation Trends At Jinxin Fertility Group (HKG:1951) Aren't Ideal
Feb 14With Jinxin Fertility Group Limited (HKG:1951) It Looks Like You'll Get What You Pay For
Dec 25What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Dec 08Jinxin Fertility Group (HKG:1951) Is Reinvesting At Lower Rates Of Return
Oct 22Jinxin Fertility Group (HKG:1951) Takes On Some Risk With Its Use Of Debt
Sep 20What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Sep 04Are Investors Undervaluing Jinxin Fertility Group Limited (HKG:1951) By 43%?
May 30Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Apr 20An Intrinsic Calculation For Jinxin Fertility Group Limited (HKG:1951) Suggests It's 34% Undervalued
Feb 27Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jan 09Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 11Some Investors May Be Worried About Jinxin Fertility Group's (HKG:1951) Returns On Capital
Nov 28Jinxin Fertility Group Limited (HKG:1951) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 03Is Jinxin Fertility Group Limited (HKG:1951) Potentially Undervalued?
Oct 04Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Sep 07Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jun 06Jinxin Fertility Group (HKG:1951) Has A Rock Solid Balance Sheet
Apr 05What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Feb 25The Returns On Capital At Jinxin Fertility Group (HKG:1951) Don't Inspire Confidence
Jan 21Why Jinxin Fertility Group Limited (HKG:1951) Could Be Worth Watching
Nov 15Jinxin Fertility Group (HKG:1951) Seems To Use Debt Quite Sensibly
Oct 11Returns On Capital At Jinxin Fertility Group (HKG:1951) Paint A Concerning Picture
Sep 28Jinxin Fertility Group Limited's (HKG:1951) Intrinsic Value Is Potentially 44% Above Its Share Price
Sep 15Should You Think About Buying Jinxin Fertility Group Limited (HKG:1951) Now?
Jul 20Shareholder Returns
| 1951 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -2.7% | 1.4% | 2.1% |
| 1Y | -10.9% | -33.2% | 12.6% |
Return vs Industry: 1951 exceeded the Hong Kong Healthcare industry which returned -33.2% over the past year.
Return vs Market: 1951 underperformed the Hong Kong Market which returned 12.6% over the past year.
Price Volatility
| 1951 volatility | |
|---|---|
| 1951 Average Weekly Movement | 14.8% |
| Healthcare Industry Average Movement | 8.1% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in HK Market | 15.5% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 1951's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1951's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 3,198 | Yang Dong | www.jxr-fertility.com |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Jinxin Fertility Group Limited Fundamentals Summary
| 1951 fundamental statistics | |
|---|---|
| Market cap | HK$8.02b |
| Earnings (TTM) | HK$306.20m |
| Revenue (TTM) | HK$3.04b |
25.8x
P/E Ratio2.6x
P/S RatioIs 1951 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1951 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.81b |
| Cost of Revenue | CN¥1.71b |
| Gross Profit | CN¥1.10b |
| Other Expenses | CN¥816.36m |
| Earnings | CN¥283.10m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 39.10% |
| Net Profit Margin | 10.07% |
| Debt/Equity Ratio | 23.0% |
How did 1951 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/14 12:11 |
| End of Day Share Price | 2025/05/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jinxin Fertility Group Limited is covered by 26 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Qianyi Li | China International Capital Corporation Limited |
| Bing Zhao | China Renaissance Securities |